Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1998
website : www.tianyuanbio.com
Main Product : Heparin Sodium, Enoxaparin Sodium, Fondaparinux Sodium, etc.
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the production of heparin and related products. Established in 1998, the company has grown to become a key player in the global pharmaceutical market, with a strong presence in both domestic and international markets. With a focus on quality and innovation, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is committed to providing safe and effective pharmaceutical products to customers worldwide.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : 1992
website : http://www.kangtai.com.cn/
Main Product : vaccines, blood products, and diagnostic reagents
Company Profile
Shenzhen Kangtai Biological Products Co., Ltd. is a renowned biopharmaceutical company that specializes in the research, development, and production of vaccines, blood products, and diagnostic reagents. With a history dating back to 1992, Kangtai has grown to become a major player in the global healthcare industry, serving markets in China, Southeast Asia, Africa, and Latin America. The company's commitment to quality and innovation has helped it establish a strong presence in the competitive biopharmaceutical market.
Changchun BCHT Biotechnology Co., Ltd.
Establishment time : 2005
website : www.bchtbiotech.com
Main Product : Biotechnology products for healthcare and agriculture
Company Profile
Changchun BCHT Biotechnology Co., Ltd. is a leading biotechnology company specializing in the development and production of cutting-edge products for healthcare and agriculture. With a focus on innovation and quality, the company has established itself as a trusted provider in the global market.
Wuhan Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.whbp.com.cn/
Main Product : vaccines, biological products
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a renowned biopharmaceutical company that specializes in the research, development, and production of vaccines and biological products. With a history dating back to 1967, the company has grown to become a key player in the healthcare industry both in China and internationally. The company is known for its high-quality products and commitment to innovation in the field of biotechnology.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2007
website : http://www.cd-biotech.com/
Main Product : Probiotics, feed additives, veterinary drugs
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. is a leading biotechnology company specializing in the production of probiotics, feed additives, and veterinary drugs. Since its establishment in 2007, the company has grown to become a key player in the industry, serving markets in China, Southeast Asia, and the Middle East. With a focus on quality and innovation, Liaoning Chengda Biotechnology Co., Ltd. continues to develop new products to meet the evolving needs of its customers.
Beijing Tiantan Biological Products Co., Ltd.
Establishment time : 1992
website : www.btbp.com.cn
Main Product : vaccines, blood products, diagnostic reagents
Company Profile
Beijing Tiantan Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. Established in 1992, the company has grown to become a major player in the healthcare industry, serving markets in China, Asia, Africa, and Latin America. With a large workforce of over 1,000 employees, the company continues to innovate and expand its product offerings while facing competition from international pharmaceutical companies. Visit their website at www.btbp.com.cn for more information.
Zhuhai United Laboratories Co., Ltd.
Establishment time : 1999
website : www.zhuhaiunited.com
Main Product : Pharmaceutical products, health supplements, medical devices
Company Profile
Zhuhai United Laboratories Co., Ltd. is a leading pharmaceutical company in China, specializing in the research, development, and production of high-quality pharmaceutical products, health supplements, and medical devices. Established in 1999, the company has grown to become a key player in the industry, serving both domestic and international markets. With a strong focus on innovation and quality, Zhuhai United Laboratories Co., Ltd. is dedicated to improving healthcare and enhancing the well-being of people worldwide.
April 27, 2024
